E-LIB Suche - Ergebnisse für: Villaruz, L.C.

1

P2.06-12 The Safety and Efficacy of Durvalumab as 1st Line ..:

Shaverdashvili, K. ; Reyes, V. ; Wang, H....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S322 , 2023

Link: https://doi.org/10.1016/..

2

A single-arm, multicenter, phase II trial of osimertinib in..:

Villaruz, L.C. ; Wang, X. ; Bertino, E.M....
ESMO Open. 8 (2023) 2 - p. 101183 , 2023

Link: https://doi.org/10.1016/..

3

EP10.01-03 A Phase 1/2 Study of REGN5093-M114, a METxMET An..:

Drilon, A. ; Awad, M.M. ; Camidge, D.R....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S602-S603 , 2023

Link: https://doi.org/10.1016/..

4

PP01.50 EMERGE-201: Phase 2 Basket Study of Lurbinectedin M..:

Spigel, D. ; Galsky, M.D. ; Heeke, A.L....
Journal of Thoracic Oncology. 18 (2023) 3 - p. e31 , 2023

Link: https://doi.org/10.1016/..

5

MA18.10 Phase 2 Multicohort Study of CC-90011, a LSD1 Inhib..:

Rudin, C.M. ; Navarro, A. ; Carcereny, E....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S169 , 2023

Link: https://doi.org/10.1016/..

6

Enrichment of Met Amplification and Kras Mutations in Non-S..:

Villaruz, L.C. ; Socinski, M.A. ; Derrick, V....
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 5 - p. S35-S36 , 2014

Link: https://doi.org/10.1016/..

7

Preliminary Results of a Phase 1b Study of Bavituximab (B) ..:

Grilley-Olson, J.E. ; Villaruz, L.C. ; Stinchcombe, T.E....
International Journal of Radiation Oncology*Biology*Physics. 90 (2014) 5 - p. S54 , 2014

Link: https://doi.org/10.1016/..

8

Tackling KRASG12C-mutated non-small-cell lung cancer: itera..:

Luo, Jia ; Villaruz, Liza C
The Lancet Respiratory Medicine. , 2024

Link: https://doi.org/10.1016/..

9

Correction: Combination of Itacitinib or Parsaclisib with P..:

Munster, Pamela ; Iannotti, Nicholas ; Cho, Daniel C....
Cancer Research Communications. 4 (2024) 3 - p. 785-785 , 2024

Link: https://doi.org/10.1158/..

10

Emerging therapeutic strategies for enhancing sensitivity a..:

Villaruz, Liza C. ; Blumenschein Jr., George R. ; Otterson, Gregory A..
Cancer. 129 (2023) 9 - p. 1319-1350 , 2023

Link: https://doi.org/10.1002/..

11

A phase II clinical trial evaluating the safety and efficac..:

Shaverdashvili, Khvaramze ; Reyes, Vincent ; Wang, Hong...
eClinicalMedicine. 66 (2023) - p. 102317 , 2023

Link: https://doi.org/10.1016/..

12

Guidance for clinicians and patients with non-small cell lu..:

Villaruz, Liza C. ; Socinski, Mark A. ; Weiss, Jared
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

13

Phase I Study of Entinostat, Atezolizumab, Carboplatin, and..:

Gentzler, Ryan D ; Villaruz, Liza C ; Rhee, John C...
The Oncologist. 28 (2023) 11 - p. 1007-e1107 , 2023

Link: https://doi.org/10.1093/..

14

Combination of Itacitinib or Parsaclisib with Pembrolizumab..:

Munster, Pamela ; Iannotti, Nicholas ; Cho, Daniel C....
Cancer Research Communications. 3 (2023) 12 - p. 2572-2584 , 2023

Link: https://doi.org/10.1158/..

15

IMpower150 Final Exploratory Analyses for Atezolizumab Plus..:

Nogami, Naoyuki ; Barlesi, Fabrice ; Socinski, Mark A....
Journal of Thoracic Oncology. 17 (2022) 2 - p. 309-323 , 2022

Link: https://doi.org/10.1016/..